Senegal loses $7m malaria grant:
This article was originally published in Clinica
Executive Summary
The Global Fund to fight AIDS, Malaria and Tuberculosis has withdrawn Senegal's $7.1m five-year grant to tackle malaria. Citing "systemic issues that resulted in poor performance" against initial two-year targets, the decision constitutes the Global Fund's first formal discontinuation and is encouraging the country to re-apply. Senegal was part of the first ever round of phase 1 evaluations conducted by the Global Fund. Another 21, with a value of $119m, were approved for a second three-year phase; three grants remain under review. The Global Fund currently has $3.1bn in phase-1 grants in 127 countries.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.